DCAF7 antibody (AA 2-100) (Cy7)
Quick Overview for DCAF7 antibody (AA 2-100) (Cy7) (ABIN1707820)
Target
See all DCAF7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 2-100
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Human,Rat,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human WDR68
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))
-
Alternative Name
- Wdr68
-
Background
-
Synonyms: AN11, Dcaf7, DCAF7_HUMAN, DDB1- and CUL4-associated factor 7, HAN11, Human anthocyanin, Petunia, Seven WD repeat protein of the AN11 family 1, SWAN 1, WD repeat domain 68, WD repeat protein An11 homolog, WD repeat-containing protein 68, WD repeat-containing protein An11 homolog, WDR68.
Background: Involved in craniofacial development. Acts upstream of the EDN1 pathway and is required for formation of the upper jaw equivalent, the palatoquadrate. The activity required for EDN1 pathway function differs between the first and second arches (By similarity). Associates with DIAPH1 and controls GLI1 transcriptional activity. Could be involved in normal and disease skin development. May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex.
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-